35 results on '"Dokken, Betsy B."'
Search Results
2. Inhibition of Nitric Oxide Synthases, But Not Inducible Nitric Oxide Synthase, Selectively Worsens Left Ventricular Function After Successful Resuscitation From Cardiac Arrest in Swine
3. Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3
4. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats
5. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes
6. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes
7. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle
8. Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat
9. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
10. Glucagon-like Peptide-1 Enhances Nitric Oxide Production by Coronary Endothelial Cells and improves Endothelium-dependent Coronary Microvascular Function after Cardiac Arrest and Resuscitation: 21
11. Reported insulin pump temperature fluctuations lack clinical relevance
12. The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids
13. The physiology of body weight regulation: are we too efficient for our own good?
14. Role of Glycogen Synthase Kinase-3 in Oxidative Stress-Induced Insulin Resistance in Type I Rat Skeletal Muscle: 2427-PO
15. Chronic Selective Glycogen Synthase Kinase-3 Inhibition Enhances Insulin Signaling and Glucose Tolerance in Pre-Diabetic Obese Zucker Rats: 1273-P
16. Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System.
17. The Parodox of glycemic control and cardiovascular complications: sorting out the data
18. Medical management of acute coronary syndromes
19. Abstract 269: Exendin-4 Prevents Glucose-induced Secretion of Tissue Transglutaminase-2 from Cardiac Microvascular Endothelial Cells: Potential Role in the Prevention of Matrix Remodeling in Diabetes
20. Role of Innate Immune Dysregulation in Diabetic Heart Failure
21. Preface
22. Glucagon‐like Peptide‐1 (GLP‐1) Attenuates Agoniststimulated Cytosolic Free Calcium ([Ca2+]i) Signaling and the Production of F2α‐isoprostane in Endothelial Cells
23. Glucagon-like peptide-1 preserves coronary microvascular endothelial function after cardiac arrest and resuscitation: potential antioxidant effects
24. How insulin analogues can benefit patients
25. The Role of Glycogen Synthase Kinase-3 in Insulin-resistant Skeletal Muscle
26. Managing Diabetes with Integrated Teams: Maximizing Your Efforts with Limited Time
27. Glucagon‐like peptide‐1 (GLP‐1) improves coronary microvascular endothelial function after cardiac arrest and resuscitation and prevents anoxia‐induced coronary microvascular endothelial cell death
28. Glucagon‐like peptide‐1 mitigates myocardial ischemia‐reperfusion injury, and is associated with differential chemokine expression
29. Treatment with Glucagon‐like Peptide‐1 During Reperfusion Decreases Ischemia‐Reperfusion Injury in Type 2 Diabetic Rat Hearts
30. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulineresistant rat skeletal muscle.
31. Optimizing technology for diabetes care.
32. Role of Glycogen Synthase Kinase-3 in Insulin Resistance and Type 2 Diabetes
33. The Art and Science of Obesity Management.
34. Postconditioning with GLP-1 in vivo Decreases Myocardial Infarct Size in Rats.
35. Glucagon-like peptide-1 preserves coronary microvascular endothelial function after cardiac arrest and resuscitation: potential antioxidant effects.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.